Whanin Pharm Co (XKRX:016580) Days Sales Outstanding : 110.22 (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Days Sales Outstanding?

Whanin Pharm Co's average Accounts Receivable for the three months ended in Mar. 2024 was ₩74,417 Mil. Whanin Pharm Co's Revenue for the three months ended in Mar. 2024 was ₩61,610 Mil. Hence, Whanin Pharm Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 110.22.

The historical rank and industry rank for Whanin Pharm Co's Days Sales Outstanding or its related term are showing as below:

XKRX:016580' s Days Sales Outstanding Range Over the Past 10 Years
Min: 112.98 Med: 151.97 Max: 163.35
Current: 112.98

During the past 13 years, Whanin Pharm Co's highest Days Sales Outstanding was 163.35. The lowest was 112.98. And the median was 151.97.

XKRX:016580's Days Sales Outstanding is ranked worse than
80.46% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs XKRX:016580: 112.98

Whanin Pharm Co's Days Sales Outstanding declined from Mar. 2023 (113.03) to Mar. 2024 (110.22).

Whanin Pharm Co Days Sales Outstanding Historical Data

The historical data trend for Whanin Pharm Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Days Sales Outstanding Chart

Whanin Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

147.98

134.43

128.24

119.37

113.09

Whanin Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															113.03	110.93	114.58	118.42	110.22

Competitive Comparison of Whanin Pharm Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Whanin Pharm Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's Days Sales Outstanding falls into.

Whanin Pharm Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Whanin Pharm Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (68241.995	+	74525.54)	/	2 )	/	230393.579	*	365
=	71383.7675					/	230393.579	*	365
=	113.09

Whanin Pharm Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (74525.54	+	74307.883)	/	2 )	/	61610.033	*	365 / 4
=	74416.7115					/	61610.033	*	365 / 4
=	110.22

Whanin Pharm Co (XKRX:016580) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Whanin Pharm Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Whanin Pharm Co (XKRX:016580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200

Website

http://www.whanin.co.kr

Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines